S

$SNSE

2 articles found
2 positive
0 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Equity-Insider.Com

Patent Cliff Accelerates Biotech Rotation: Five Precision Oncology Firms Poised for Breakthrough

Institutional investors rotate capital to precision oncology biotech as patent cliff pressures Big Pharma. Five clinical-stage companies positioned for M&A amid $303B market opportunity.
SNSEONCYTNGXOSTXATOSFDA approvalbiotech
BenzingaBenzinga··Vandana Singh

Sensei Biotherapeutics Surges on Faeth Acquisition and $200M Investment

Sensei Biotherapeutics stock surged 230% after acquiring Faeth Therapeutics and securing $200M investment, expanding its oncology pipeline with PIKTOR therapy.
SNSEacquisitionbiotech